Digital Pathology Market to Surpass US$ 3.86 Billion by 2033 as AI-Enabled Diagnostics and Telepathology Redefine Global Healthcare | DataM Intelligence

Download Exclusive Sample Report: https://www.datamintelligence.com/download-sample/digital-pathology-market   Download Exclusive Sample Report:https://www.datamintelligence.com/download-sample/digital-pathology-market  Browse in-depth TOC on "Digital Pathology Market"  70 – Tables 66 – Figures 195 – Pages Market Segmentation Insights By Product Hardware Devices remained the largest segment in 2024, valued atUS$ 650 million,  led by demand for high-resolution...

Download Exclusive Sample Report: https://www.datamintelligence.com/download-sample/digital-pathology-market  

Browse in-depth TOC on "Digital Pathology Market" 

70 – Tables
66 – Figures
195 – Pages

Market Segmentation Insights

By Product

Hardware Devices remained the largest segment in 2024, valued at US$ 650 million, led by demand for high-resolution slide scanners and imaging platforms.

Software solutions, generating US$ 420 million in 2024, are experiencing the fastest CAGR, driven by AI-powered diagnostic algorithms, cloud-based platforms, and integration with hospital information systems.

Services, including managed platforms, consulting, and workflow integration, contributed US$ 240 million in 2024, as hospitals and labs seek end-to-end digital transformation.

By Type

Human Pathology dominated in 2024, generating over US$ 1.05 billion, reflecting widespread adoption in cancer and chronic disease diagnostics.

Veterinary Pathology, valued at US$ 260 million, is expanding steadily, with applications in livestock, companion animals, and zoonotic disease research.

By Application

By End-User

Hospitals remained the largest end-user in 2024 (US$ 540 million), as integrated pathology workflows became central to cancer care and diagnostics.

Diagnostic Laboratories contributed US$ 410 million, with high-throughput slide analysis enhancing efficiency and turnaround times.

Academic & Research Institutes (US$ 240 million) and Veterinary Clinics (US$ 120 million) are also adopting digital solutions to enhance accuracy and scalability.

Request for Customized Sample Report as per Your Business Requirement: https://www.datamintelligence.com/customize/digital-pathology-market

Regional Insights: USA & Japan

United States

The U.S., valued at US$ 530 million in 2024, remains the global leader due to:

Japan

Japan's market, valued at US$ 115 million in 2024, is expanding rapidly. Key drivers include:

Industry Trends & Developments

Competitive Landscape: Key Players

Koninklijke Philips N.V.

Philips leads with its IntelliSite Pathology Solution, FDA-cleared and widely adopted across hospitals and labs. The company generated US$ 280 million from digital pathology in 2024 and is focusing on AI and cloud integration.

F. Hoffmann-La Roche Ltd

Roche continues to dominate through its VENTANA digital pathology portfolio, tightly integrated with oncology diagnostics. Roche's 2024 digital pathology revenues exceeded US$ 250 million, supported by strong U.S. and Japan adoption.

Hamamatsu Photonics K.K.

A key innovator in Japan, Hamamatsu is expanding its NanoZoomer scanners for both clinical and research markets. In 2025, it launched new AI-enhanced scanners tailored for Japanese hospitals.

PathAI, Inc. & Proscia Inc.

Both U.S.-based firms are scaling AI-driven software platforms. PathAI secured multi-year contracts with pharma companies in 2025, while Proscia expanded its Concentriq platform into Europe and Asia.

Visiopharm A/S & 3DHISTECH Ltd.

Visiopharm continues to lead in AI image analysis, while 3DHISTECH's whole-slide scanners remain competitive in academic institutions worldwide.

Buy This Exclusive Report at Just USD 4350 Only: https://www.datamintelligence.com/buy-now-page?report=digital-pathology-market 

Strategic Outlook

The Digital Pathology Market is expected to triple in value, reaching US$ 3.86 Billion by 2033. The next decade will be defined by:

Conclusion

The global Digital Pathology Market is at the forefront of healthcare's digital transformation. With revenues projected to climb from US$ 1.31 Billion in 2024 to US$ 3.86 Billion by 2033, the sector represents a critical enabler of precision diagnostics, efficient workflows, and scalable healthcare delivery.

With the U.S. shaping global adoption and Japan setting innovation benchmarks in Asia, digital pathology is poised to become an indispensable pillar of clinical medicine and research.

Related Reports:

1.      Anatomic Pathology Market Size to Soar to USD 31.1 B by 2030, Fueled by Digital & Molecular Diagnostics.

2.      North America Digital Pathology Market Size Poised for Rapid Growth: Projected from USD 449M in 2024 to USD 694M by 2030 on AI & Telepathology Surge.

3.      Europe Digital Pathology Market to Quadruple by 2033: AI & Telepathology Drive EUR-Scale Growth.

Request for Trial Access of AI-Driven Database Subscription Platform: https://www.datamintelligence.com/reports-subscription 

Features of AI-Driven DataM Insights Database Subscription:

Contact:

Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: [email protected]

Logo: https://mma.prnewswire.com/media/1858619/3573087/DataM_Intelligence_Logo.jpg

 

 

View original content:https://www.prnewswire.co.uk/news-releases/digital-pathology-market-to-surpass-us-3-86-billion-by-2033-as-ai-enabled-diagnostics-and-telepathology-redefine-global-healthcare--datam-intelligence-302567297.html